Janssen Pharmaceutica N.V.

Belgium


Create a watch for Janssen Pharmaceutica N.V.
Total IP 3,351
Total IP Rank # 368
IP Activity Score 3.7/5.0    1,061
IP Activity Rank # 681
Parent Entity Johnson & Johnson
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

1,059 1
375 2
1,126 785
3
 
Last Patent 2025 - Radiolabelled mgl pet ligands
First Patent 1974 - Benzimidazolinone derivatives
Last Trademark 2025 - ORPEPTRY
First Trademark 1959 - REASEC

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 G/S Pharmaceutical preparations for human use.
G/S Medical apparatus for introducing pharmaceutical preparations into the human body, also for urol...
G/S Pharmaceutical preparations for the treatment of cancer.
Invention Radiolabelled mgl pet ligands. The present invention relates to novel, selective, radiolabeled c...
Invention Antibodies to pyroglutamate amyloid-b and uses thereof. The invention provides antibodies or ant...
G/S Pharmaceutical preparations for the treatment and prevention of autoimmune diseases and disorder...
Invention Seltorexant for use in treating major depressive disorder with insomnia symptoms. The disclosure ...
Invention Crystal forms of peptide molecules. The present disclosure relates to crystalline forms of compou...
Invention Mapt sirna and uses thereof. Provided herein are small interfering ribonucleic acid (siRNA) agent...
Invention Enrichment of cells expressing a bird linker. The disclosure provided herein relates to methods o...
Invention Anti-human vista antibodies and use thereof. The invention provides agonistic anti-human VISTA a...
Invention Formulations, crystalline forms and dosage regimens of a malt1 inhibitor. The present invention r...
Invention Inhibitors of malt1 and methods of their use. Methods for treating a B-cell malignancy in a human...
Invention Methods and systems for microbial detection using raman and infrared spectroscopy. Provided is a ...
Invention Cell manufacturing management platform using machine learning. A cell manufacturing management pl...
Invention Compounds and uses thereof. The present invention features compounds useful in the treatment of ...
Invention Imidazopyridazine il-17 inhibitor compounds. The present application discloses compounds having t...
G/S Pharmaceutical preparations.
G/S Human pharmaceutical preparations for the prevention and treatment of auto-immune and inflammato...
Invention Triazolo[4,5-b]pyridine compounds useful as inhibitors of werner syndrome recq helicase (wrn). Th...
Invention Substituted pyrrolidine-2-carboxylic acid derivatives as cgas inhibitors. [0366] Compounds of For...
Invention Substituted pyrrolidine-2-carboxylic acid derivatives as cgas inhibitors. Compounds of Formula (...
Invention Lipids for nanoparticle delivery platform. The present disclosure includes ionizable lipids suita...
Invention Crystal form of a peptide inhibitor of interleukin-23 receptor. The present disclosure relates to...
Invention Methods for the treatment of depression. The present invention is directed to methods and dosing...
Invention Crystalline forms of 3-(7-chloro-1h-indazol-5-yl)-2,5-bis(trifluoromethyl)-3h-imidazo[4,5-b]pyrid...
Invention Pharmaceutical composition of s-ketamine hydrochloride. The present invention is directed to an ...
Invention Methods of treating depression using orexin-2 receptor antagonists. The present disclosure is di...
Invention Peptide inhibitors of interleukin-23 receptor and uses thereof. Uses of a peptide inhibitor of th...
Invention Coronavirus inhibiting compounds. The present invention relates to compounds of formula (I) for t...
2024 Invention Anti-vista antibodies and fragments. The present invention relates to novel antibodies and fragm...
Invention Imidazopyridazine il-17 inhibitor compounds. The present application discloses compounds having ...
Invention Methods for treating subjects with autism spectrum disorder. A method of treating Autism Spectrum...
Invention Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic gl...
Invention Synthesis of a bruton's tyrosine kinase inhibitor. Described herein is the synthesis of Bruton's...
G/S Medical apparatus and instruments for use in surgery; surgical apparatus and instruments.
G/S Medical apparatus and instruments for use in surgery; surgical apparatus and instruments; trocar...
2023 Invention Blood-based screening of subjects for a clinical trial for treatment of tauopathy or amyloidogeni...
Invention Collaborative frameworks for improving regulatory decision-making of measurement solutions. In a...
Invention Methods for mitigating lung injury in conjunction with exposure to radiation and/or radiation or ...
Invention Pyrrolidione derivatives as inhibitors of nf kappa b inducing kinase. The present disclosure rel...
Invention Pyrrolidinone derivatives as inhibitors of nf kappa b inducing kinase. The present disclosure re...
Invention Metabolite predictors for lung cancer. Disclosed herein are methods for analyzing predictors inc...
Invention Crystalline forms of an inhibitor of the menin/mll interaction. The present invention relates to...
Invention Multispecific antibodies and uses thereof. Provided are multispecific antibodies or antigen bind...
Invention Expression systems for the alpha6-containing nicotinic acetylcholine receptor and methods of use ...
Invention Niraparib and abiraterone acetate plus prednisone to improve clinical outcomes in patients with m...
Invention Antagonist of adenosine receptors. The present invention relates to compounds of formula I shown...
2022 G/S Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immun...
G/S Pharmaceutical preparations for the treatment of cancer for human use.
G/S Vaccines.
G/S Human pharmaceutical preparations for the prevention and treatment of oncological diseases and d...
Invention Pyridazines or 1,2,4-triazines substituted by spirocyclic amines. The present invention relates ...
Invention Combination therapies. Disclosed are combinations comprising a therapeutically effective amount ...
Invention Expression systems for the alpha2alpha5beta2 nicotinic acetylcholine receptor and methods of use ...
Invention Expression systems for the alpha6beta4 nicotinic acetylcholine receptor and methods of use thereo...
Invention Methods for identifying binding partners of progranulin. Disclosed herein are screening methods ...
2020 Invention Intranasal drug delivery device